Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06878950 · ClinicalTrials.gov registry record · NA

Early Feeds in Gastroschisis

A NA study of Gastroschisis, sponsored by University of California, Davis.

Recruiting
Registry status
NA
Development phase
20
Enrollment target
2
Study locations

NCT06878950 is a NA study of Gastroschisis that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 20 participants, below the 92-participant average among 4 other Gastroschisis trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06878950, a NA study of Gastroschisis, is actively recruiting participants, sponsored by University of California, Davis.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
2
Study locations

Study Summary

This study aims to evaluate the feasibility of initiating early feeds in neonates with gastroschisis, a condition where infants are born with their intestines outside the body.

Conditions Studied

Interventions

  • PROCEDURE Early Feeding Protocol

Study Locations (2)

California

  • University of California Los Angeles - Los Angeles
  • UC Davis Children's Hospital - Sacramento

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-02-24
Est. Completion 2029-02-01
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT06878950

The ClinicalTrials.gov registry entry for NCT06878950 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 92-participant average among 4 other Gastroschisis trials with a reported enrollment target (78% lower). The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Gastroschisis appearing as the primary indexed condition, and to 1 intervention - of which Early Feeding Protocol is the first listed.

NCT06878950 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06878950 about?

NCT06878950 is a clinical study titled "Early Feeds in Gastroschisis". This study aims to evaluate the feasibility of initiating early feeds in neonates with gastroschisis, a condition where infants are born with their intestines outside the body.

What is the current status of trial NCT06878950?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-02-24. Estimated completion is 2029-02-01.

What conditions does trial NCT06878950 study?

This clinical trial studies the following conditions: Gastroschisis.

What interventions are being tested in trial NCT06878950?

The interventions under investigation include: Early Feeding Protocol (PROCEDURE).

Who is sponsoring clinical trial NCT06878950?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06878950 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroschisis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.